ABSTRACT
Limited resources affect an organism's physiology through the conserved metabolic pathway, the mechanistic target of rapamycin (mTOR). Males and females often react differently to nutritional limitation, but whether it leads to differential mTOR pathway expression remains unknown. Recently, we found that dietary restriction (DR) induced significant changes in the expression of mTOR pathway genes in female Japanese quails (Coturnix japonica). We simultaneously exposed 32 male and female Japanese quails to either 20%, 30%, 40% restriction or ad libitum feeding for 14 days and determined the expression of six key genes of the mTOR pathway in the liver to investigate sex differences in the expression patterns. We found that DR significantly reduced body mass, albeit the effect was milder in males compared to females. We observed sex-specific liver gene expression. DR downregulated mTOR expression more in females than in males. Under moderate DR, ATG9A and RPS6K1 expressions were increased more in males than in females. Like females, body mass in males was correlated positively with mTOR and IGF1, but negatively with ATG9A and RS6K1 expressions. Our findings highlight that sexes may cope with nutritional deficits differently and emphasise the importance of considering sexual differences in studies of dietary restriction.
Subject(s)
Coturnix , Sirolimus , Animals , Female , Male , Coturnix/metabolism , Sirolimus/metabolism , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/metabolismABSTRACT
The intricate evolutionary dynamics of endosymbiotic relationships result in unique characteristics among the genomes of symbionts, which profoundly influence host insect phenotypes. Here, we investigated an endosymbiotic system in Phenacoccus solenopsis, a notorious pest of the subfamily Phenacoccinae. The endosymbiont, "Candidatus Tremblaya phenacola" (T. phenacola PSOL), persisted throughout the complete life cycle of female hosts and was more active during oviposition, whereas there was a significant decline in abundance after pupation in males. Genome sequencing yielded an endosymbiont genome of 221.1 kb in size, comprising seven contigs and originating from a chimeric arrangement between betaproteobacteria and gammaproteobacteria. A comprehensive analysis of amino acid metabolic pathways demonstrated complementarity between the host and endosymbiont metabolism. Elimination of T. phenacola PSOL through antibiotic treatment significantly decreased P. solenopsis fecundity. Weighted gene coexpression network analysis demonstrated a correlation between genes associated with essential amino acid synthesis and those associated with host meiosis and oocyte maturation. Moreover, altering endosymbiont abundance activated the host mechanistic target of rapamycin pathway, suggesting that changes in the amino acid abundance affected the host reproductive capabilities via this signal pathway. Taken together, these findings demonstrate a mechanism by which the endosymbiont T. phenacola PSOL contributed to high fecundity in P. solenopsis and provide new insights into nutritional compensation and coevolution of the endosymbiotic system.
Subject(s)
Betaproteobacteria , Gammaproteobacteria , Hemiptera , Animals , Male , Female , Sirolimus/metabolism , Betaproteobacteria/genetics , Gammaproteobacteria/genetics , Hemiptera/microbiology , Reproduction , Amino Acids/metabolism , SymbiosisABSTRACT
Plant growth is intimately linked to the availability of carbon and energy status. The Target of rapamycin (TOR) pathway is a highly relevant metabolic sensor and integrator of plant-assimilated C into development and growth. The cell wall accounts for around a third of the cell biomass, and the investment of C into this structure should be finely tuned for optimal growth. The plant C status plays a significant role in controlling the rate of cell wall synthesis. TOR signaling regulates cell growth and expansion, which are fundamental processes for plant development. The availability of nutrients and energy, sensed and integrated by TOR, influences cell division and elongation, ultimately impacting the synthesis and deposition of cell wall components. The plant cell wall is crucial in environmental adaptation and stress responses. TOR senses and internalizes various environmental cues, such as nutrient availability and stresses. These environmental factors influence TOR activity, which modulates cell wall remodeling to cope with changing conditions. Plant hormones, including auxins, gibberellins, and brassinosteroids, also regulate TOR signaling and cell wall-related processes. The connection between nutrients and cell wall pathways modulated by TOR are discussed.
Subject(s)
Sirolimus , TOR Serine-Threonine Kinases , TOR Serine-Threonine Kinases/metabolism , Sirolimus/metabolism , Plant Development/physiology , Signal Transduction/physiology , Plants/metabolism , Cell Wall/metabolismABSTRACT
Matrix metalloproteinase 9 (MMP9) plays a pivotal role in mammary ductal morphogenesis, angiogenesis and glandular tissue architecture remodeling. However, the molecular mechanism of MMP9 expression in mammary epithelial cells of dairy cows remains unclear. This study aimed to explore the underlying mechanism of MMP9 expression. In this study, to determine whether the PI3K/AKT/mTORC1/NF-κB signalling pathway participates in the regulation of MMP9 expression, we treated mammary epithelial cells with specific pharmacological inhibitors of PI3K (LY294002), mTORC1 (Rapamycin) or NF-κB (Celastrol), respectively. Western blotting results indicated that LY294002, Rapamycin and Celastrol markedly decreased MMP9 expression and P65 nuclear translocation. Furthermore, we found that NF-κB (P65) overexpression resulted in elevated expression of MMP9 protein and activation of MMP9 promoter. In addition, we observed that Celastrol markedly decreases P65-overexpression-induced MMP9 promoter activity. Moreover, the results of the promoter assay indicated that the core regulation sequence for MMP9 promoter activation may be located at -420 â¼ -80 bp downstream from the transcription start site. These observations indicated that the PI3K/AKT/mTORC1 signalling pathway is involved in MMP9 expression by regulating MMP9 promoter activity via NF-κB in the mammary epithelial cells of dairy cows.
Subject(s)
NF-kappa B , Pentacyclic Triterpenes , Proto-Oncogene Proteins c-akt , Female , Cattle , Animals , NF-kappa B/genetics , NF-kappa B/metabolism , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Phosphatidylinositol 3-Kinases/genetics , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Transcriptional Activation , Mechanistic Target of Rapamycin Complex 1/genetics , Mechanistic Target of Rapamycin Complex 1/metabolism , Epithelial Cells/metabolism , Sirolimus/metabolism , Sirolimus/pharmacologyABSTRACT
BACKGROUND: Increasing evidence suggests that mitochondrial dysfunction plays a significant role in PTSD. However, the exact mechanism is still unclear. Mitochondrial dynamics could be one of the mechanisms, as it is crucial for mitochondrial homeostasis and is widely affected in traumatic situations. Mitochondrial dynamics regulate mitochondrial homeostasis via orexinergic receptors, and it is shown that antagonism of orexinergic receptors attenuates PTSD-like symptoms. Therefore, the present study aimed to determine how orexin antagonists affect mitochondrial dynamics in rats exhibiting PTSD-like symptoms. METHODS: Using rats, a stress-re-stress (SRS) model with PTSD-like symptoms was established. On day 2 (D-2), the animals were exposed to variable stressors including 2 h of restraint followed by brief mild foot shock and exposure to 4%halothane. Foot shock was performed as a re-stress from D-8 to D-32 at six-day intervals. RESULTS: SRS exposure caused PTSD-like phenotype, hypothalamic-pituitary-adrenal axis dysfunction, activation of mammalian target of rapamycin (mTOR), and mitochondrial-fission-process-1 (MTFP-1). SRS-subjected rats exhibited enhanced expression of fission-regulating proteins, including dynamin-related protein-1 and mitochondrial-fission-protein-1 and reduced expression of fusion-regulating proteins, including optic-atrophy-1 and mitofusin-2, in the amygdala. TEM analysis revealed that SRS exposure further damaged the mitochondria. Treatment with suvorexant with rapamycin significantly mitigated PTSD-like symptoms and improved mitochondrial dynamics in SRS-exposed rats. However, their combination showed a more pronounced effect. Further, suvorexant in combination with rapamycin significantly mitigated mTOR and MTFP-1 activation. Sertraline attenuated PTSD-like symptoms without affecting SRS-induced activation of mTOR and disparity in mitochondrial dynamics. Suvorexant pharmacological effects on mitochondrial biogenesis also involve the mTOR pathway. LIMITATION: The role of orexinergic pathway in SRS-induced mitochondrial mitophagy was not explored. CONCLUSIONS: Targeting both the orexinergic and mTOR pathways might exert a beneficial synergistic effect for treating PTSD.
Subject(s)
Azepines , Stress Disorders, Post-Traumatic , Triazoles , Rats , Animals , Hypothalamo-Hypophyseal System/metabolism , Mitochondrial Dynamics , Pituitary-Adrenal System/metabolism , TOR Serine-Threonine Kinases/metabolism , Sirolimus/metabolism , Sirolimus/pharmacology , Sirolimus/therapeutic use , Mammals/metabolismABSTRACT
BACKGROUND: Many viruses enter host cells by hijacking endosomal trafficking. CapZ, a canonical actin capping protein, participates in endosomal trafficking, yet its precise role in endocytosis and virus infection remains elusive. RESULTS: Here, we showed that CapZ was transiently associated with early endosomes (EEs) and was subsequently released from the matured EEs after the fusion of two EEs, which was facilitated by PI(3)P to PI(3,5)P2 conversion. Vacuolin-1 (a triazine compound) stabilized CapZ at EEs and thus blocked the transition of EEs to late endosomes (LEs). Likewise, artificially tethering CapZ to EEs via a rapamycin-induced protein-protein interaction system blocked the early-to-late endosome transition. Remarkably, CapZ knockout or artificially tethering CapZ to EEs via rapamycin significantly inhibited flaviviruses, e.g., Zika virus (ZIKV) and dengue virus (DENV), or beta-coronavirus, e.g., murine hepatitis virus (MHV), infection by preventing the escape of RNA genome from endocytic vesicles. CONCLUSIONS: These results indicate that the temporal association of CapZ with EEs facilitates early-to-late endosome transition (physiologically) and the release of the viral genome from endocytic vesicles (pathologically).
Subject(s)
Phosphatidylinositol Phosphates , Zika Virus Infection , Zika Virus , Animals , Humans , Mice , Endocytosis/physiology , Endosomes/metabolism , Sirolimus/pharmacology , Sirolimus/metabolism , Transport Vesicles , Virus Internalization , Zika Virus Infection/metabolismABSTRACT
Human induced pluripotent stem cells (hiPSCs) are promising in regenerative medicine. However, the pluripotent stem cells (PSCs) may form clumps of cancerous tissue, which is a major safety concern in PSCs therapies. Rapamycin is a safe and widely used immunosuppressive pharmaceutical that acts through heterodimerization of the FKBP12 and FRB fragment. Here, we aimed to insert a rapamycin inducible caspase 9 (riC9) gene in a safe harbor AAVS1 site to safeguard hiPSCs therapy by drug induced homodimerization. The donor vector containing an EF1α promoter, a FRB-FKBP-Caspase 9 (CARD domain) fusion protein and a puromycin resistant gene was constructed and co-transfected with sgRNA/Cas9 vector into hiPSCs. After one to two weeks screening with puromycin, single clones were collected for genotype and phenotype analysis. Finally, rapamycin was used to induce the homodimerization of caspase 9 to activate the apoptosis of the engineered cells. After transfection of hiPSCs followed by puromycin screening, five cell clones were collected. Genome amplification and sequencing showed that the donor DNA has been precisely knocked out at the endogenous AAVS1 site. The engineered hiPSCs showed normal pluripotency and proliferative capacity. Rapamycin induced caspase 9 activation, which led to the apoptosis of all engineered hiPSCs and its differentiated cells with different sensitivity to drugs. In conclusion, we generated a rapamycin-controllable hiPSCs survival by homodimerization of caspase 9 to turn on cell apoptosis. It provides a new strategy to guarantee the safety of the hiPSCs therapy.
Subject(s)
Humans , Induced Pluripotent Stem Cells , Sirolimus/metabolism , Caspase 9/metabolism , RNA, Guide, CRISPR-Cas Systems , Pluripotent Stem Cells/metabolism , Cell Differentiation , Puromycin/metabolismABSTRACT
En este artículo de revisión, queremos destacar las principales novedades y curiosidades alrededor de la cirugía de columna que se han publicado el año 2015. Aunque, el año pasado no han sido publicadas grandes novedades en nuestra área de estudio, nosotros queremos hacer hincapié en los aspectos que nos han parecido más relevantes sobre cirugía de columna. Dado que la cirugía de columna representa una importante carga asistencial sanitaria y social. Los estudios aquí reflejados intentan dar respuestas a las múltiples demandas pendientes. Así es como abordaremos temas como la artrodesis cervical vs prótesis cervicales, uso local de vancomicina en polvo, vitamina D, mejoras en las técnicas de cementación vertebral, uso de agentes biológicos, escoliosis idiopática del adolescente y factores de riesgo para la cirugía de columna
In this revision article we want to highlight some news and curiosities around the spine surgery published during 2015. Although last year, they have not been published major innovations in spinal surgery, we want to emphasize some aspects that we consider interesting and useful in our working area. Spinal surgery is a major social and health burden, so the studies reflected here attempt to answer outstanding claims. This is how we address issues such as cervical arthrodesis vs cervical prostheses, use of local powder vancomycin, use of vitamin D, improving vertebral cementation techniques, risk factors for spine surgery, use of biological agents and adolescent idiopathic scoliosis
Subject(s)
Humans , Male , Female , Spine/physiology , Prostheses and Implants , Prostheses and Implants/supply & distribution , Cervical Rib/injuries , Vancomycin/administration & dosage , Pedicle Screws/standards , Sirolimus/supply & distribution , Bone Morphogenetic Proteins/administration & dosage , Scoliosis/diagnosis , Vitamin D/administration & dosage , Spine/pathology , Prostheses and Implants/classification , Prostheses and Implants/standards , Cervical Rib/pathology , Vancomycin/metabolism , Pedicle Screws , Sirolimus/metabolism , Bone Morphogenetic Proteins/supply & distribution , Scoliosis/complications , Vitamin D/metabolismABSTRACT
La linfangioleiomiomatosis (LAM) es una enfermedad rara que se caracteriza por la proliferación anormal de células musculares lisas atípicas (células LAM) que condicionan la destrucción del parénquima pulmonar con formación de quistes. A pesar de que el trasplante pulmonar se considera la única opción terapéutica cuando la enfermedad progresa, ensayos clínicos recientes muestran que el tratamiento con sirolimus, fármaco inhibidor de mTOR (mammalian target of rapamycin), puede tener un efecto beneficioso sobre la función pulmonar y la reducción del tamaño de los angiomiolipomas renales que se asocian a la LAM. Presentamos el caso de una mujer de 20 años, diagnosticada de linfangioleiomiomatosis asociada a esclerosis tuberosa, en tratamiento con sirolimus
Lymphangioleiomyomatosis (LAM) is a rare disease that affects young females in their reproductive years. It is characterized by proliferation of abnormal smooth muscle-like cells (LAM cells) leading to progressive cystic destruction of the lung. Even though lung transplantation is considered the only treatment for severe LAM, some recent trials of sirolimus (mTOR inhibitor) showed that there was an improvement in lung function and a reduction in the size of renal angiomyolipomas. We report the case of a twenty years old woman with LAM associated to the tuberous sclerosis complex, who is being treated with sirolimus
Subject(s)
Female , Humans , Sirolimus/administration & dosage , Sirolimus , Therapeutics/nursing , Therapeutics/psychology , Cells/cytology , Cells/pathology , Cysts/chemically induced , Cysts/nursing , Tuberous Sclerosis/complications , Tuberous Sclerosis/genetics , Sirolimus/metabolism , Sirolimus/supply & distribution , Therapeutics/instrumentation , Therapeutics/methods , Cells/chemistry , Cells/classification , Cysts/complications , Cysts/metabolism , Tuberous Sclerosis/metabolism , Tuberous Sclerosis/pathologyABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Sirolimus , Sirolimus/metabolism , Drug-Eluting Stents/standards , Drug-Eluting Stents , Angiography/instrumentation , Angiography/methods , Drug-Eluting Stents/trends , Tomography, Optical Coherence/methods , Tomography, Optical CoherenceABSTRACT
El trasplante de órganos, uno de los avances más sorprendentes de la medicina junto con el desarrollo de agentes inmunosupresores cada vez más eficaces, modificó el curso de enfermedades terminales devastadoras. Sin embargo, esta práctica médica nos enfrenta a una población cada vez más longeva que padece las complicaciones secundarias de la inmunosupresión crónica, necesaria para asegurar la supervivencia del injerto. La elevada incidencia de neoplasias interna y, en particular, cutáneas plantea la necesidad de un manejo interdisciplinario. En este sentido, el médico dermatólogo desempeña un papel protagónico en la prevención, el diagnóstico y el tratamiento de estos procesos malignos.
Subject(s)
Humans , Immunosuppressive Agents/adverse effects , Sirolimus/metabolism , Sirolimus/therapeutic use , Skin Neoplasms/etiology , Skin Neoplasms/pathology , Skin Neoplasms/drug therapy , Skin Neoplasms/therapy , Sarcoma, Kaposi/pathology , Sarcoma, Kaposi/therapy , Tissue TransplantationABSTRACT
No disponible